Clinical Trial Update: Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate) [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial evaluating ablative radiotherapy to consolidate maximal systemic response in metastatic prostate cancer is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Prostate Cancer Metastatic | Phase 2 | Status: RECRUITING